Global Wealth Management Investment Advisory’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
– Sell
-45
Closed -$3K – 621
2020
Q1
$3K Buy
+45
New +$3.25K ﹤0.01% 465
2019
Q4
– Sell
-27
Closed -$2K – 651
2019
Q3
$2K Hold
27
– – ﹤0.01% 508
2019
Q2
$2K Hold
27
– – ﹤0.01% 556
2019
Q1
$2K Hold
27
– – ﹤0.01% 542
2018
Q4
$1K Buy
+27
New +$1.37K ﹤0.01% 638

Other funds holding EW

Global Wealth Management Investment Advisory's EW Position: Q2 2020 in Review

Global Wealth Management Investment Advisory sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 45 shares — an estimated $3K sold.

Global Wealth Management Investment Advisory first reported a position in EW in Q4 2018 and held it in 5 quarters. The position peaked at $3K in Q1 2020. 1,048 funds tracked by Wall St. Rank hold EW as of Q2 2020.

  • Global Wealth Management Investment Advisory reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
  • Global Wealth Management Investment Advisory sold 45 Edwards Lifesciences shares in Q2 2020, an estimated $3K.
  • Global Wealth Management Investment Advisory first reported a position in Edwards Lifesciences in Q4 2018 and held it in 5 quarters.
  • Global Wealth Management Investment Advisory's Edwards Lifesciences position peaked at $3K in Q1 2020.
  • 1,048 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on Global Wealth Management Investment Advisory's 13F filing for Q2 2020, filed 12 Aug 2020.